开云app官网登录入口网页版-官方正版

#丙肝药#

23篇内容 | 1227人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2040125, encodeId=977f204012584, content=<a href='/topic/show?id=ecf72093855' target=_blank style='color:#2F92EE;'>#丙肝药#</a>, objectTitle=吉利德的丙肝药物Epclusa在儿童感染患者中应答率超过90%，喜获FDA批准, objectType=article, longId=190494, objectId=01b81904941b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01b81904941b, replyNumber=0, likeNumber=71, createdTime=2020-12-27, rootId=0, userName=bioon3, userId=322359, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01b81904941b, moduleTitle=吉利德的丙肝药物Epclusa在儿童感染患者中应答率超过90%，喜获FDA批准, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=01b81904941b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040126, encodeId=cd78204012607, content=<a href='/topic/show?id=ecf72093855' target=_blank style='color:#2F92EE;'>#丙肝药#</a>, objectTitle=吉利德全新慢性丙肝药物“吉三代”沃士韦在中国上市，10万以内搞定丙肝, objectType=article, longId=197037, objectId=381719e037b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=381719e037b2, replyNumber=0, likeNumber=67, createdTime=2020-12-18, rootId=0, userName=bioon3, userId=322359, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=381719e037b2, moduleTitle=吉利德全新慢性丙肝药物“吉三代”沃士韦在中国上市，10万以内搞定丙肝, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=381719e037b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040124, encodeId=732e20401241d, content=<a href='/topic/show?id=ecf72093855' target=_blank style='color:#2F92EE;'>#丙肝药#</a>, objectTitle=美国FDA首次批准儿童全基因型抗丙肝药物：艾伯维的Mayyret, objectType=article, longId=165452, objectId=7fcf1654522f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fcf1654522f, replyNumber=0, likeNumber=65, createdTime=2019-06-06, rootId=0, userName=bioon3, userId=322359, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fcf1654522f, moduleTitle=美国FDA首次批准儿童全基因型抗丙肝药物：艾伯维的Mayyret, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7fcf1654522f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040123, encodeId=ed312040123fb, content=<a href='/topic/show?id=ecf72093855' target=_blank style='color:#2F92EE;'>#丙肝药#</a>, objectTitle=警惕这种仿制丙肝药，会害了成千上万的患者！, objectType=article, longId=129950, objectId=f38712995051, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f38712995051, replyNumber=0, likeNumber=62, createdTime=2018-04-29, rootId=0, userName=bioon3, userId=322359, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f38712995051, moduleTitle=警惕这种仿制丙肝药，会害了成千上万的患者！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f38712995051)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040122, encodeId=9e732040122c6, content=<a href='/topic/show?id=ecf72093855' target=_blank style='color:#2F92EE;'>#丙肝药#</a>, objectTitle=【盘点】近期关于丙肝药-索非布韦的研究进展一览, objectType=article, longId=115288, objectId=206011528864, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=206011528864, replyNumber=0, likeNumber=64, createdTime=2018-03-08, rootId=0, userName=bioon3, userId=322359, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=206011528864, moduleTitle=【盘点】近期关于丙肝药-索非布韦的研究进展一览, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=206011528864)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040121, encodeId=3825204012150, content=<a href='/topic/show?id=ecf72093855' target=_blank style='color:#2F92EE;'>#丙肝药#</a>, objectTitle=EMA支持批准两种丙肝药物Epclusa和Zepatier, objectType=article, longId=69658, objectId=bcea69658f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bcea69658f0, replyNumber=0, likeNumber=0, createdTime=2016-11-08, rootId=0, userName=bioon3, userId=322359, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bcea69658f0, moduleTitle=EMA支持批准两种丙肝药物Epclusa和Zepatier, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=bcea69658f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040120, encodeId=79b3204012034, content=<a href='/topic/show?id=ecf72093855' target=_blank style='color:#2F92EE;'>#丙肝药#</a>, objectTitle=默沙东战胜吉利德，赢取首轮丙肝药专利权大战, objectType=article, longId=68151, objectId=7e776815114, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e776815114, replyNumber=0, likeNumber=64, createdTime=2016-07-01, rootId=0, userName=bioon3, userId=322359, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e776815114, moduleTitle=默沙东战胜吉利德，赢取首轮丙肝药专利权大战, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7e776815114)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040119, encodeId=b06b2040119d6, content=<a href='/topic/show?id=ecf72093855' target=_blank style='color:#2F92EE;'>#丙肝药#</a>, objectTitle=沙东战胜吉利德，赢取首轮丙肝药专利权大战, objectType=article, longId=65584, objectId=0b9e65584d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b9e65584d3, replyNumber=0, likeNumber=58, createdTime=2016-05-12, rootId=0, userName=bioon3, userId=322359, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b9e65584d3, moduleTitle=沙东战胜吉利德，赢取首轮丙肝药专利权大战, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0b9e65584d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040118, encodeId=bbd920401182a, content=<a href='/topic/show?id=ecf72093855' target=_blank style='color:#2F92EE;'>#丙肝药#</a>, objectTitle=NEJM：丙肝药物Sofosbuvir和Velpatasvir联用大获成功，肝硬化依然有效（ASTRAL系列研究）, objectType=article, longId=60052, objectId=a2a260052e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2a260052e3, replyNumber=0, likeNumber=67, createdTime=2016-04-14, rootId=0, userName=bioon3, userId=322359, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2a260052e3, moduleTitle=NEJM：丙肝药物Sofosbuvir和Velpatasvir联用大获成功，肝硬化依然有效（ASTRAL系列研究）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a2a260052e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040117, encodeId=03da204011e32, content=<a href='/topic/show?id=ecf72093855' target=_blank style='color:#2F92EE;'>#丙肝药#</a>, objectTitle=NEJM：丙肝药索非布韦对心脏有潜在的毒副作用？, objectType=article, longId=58412, objectId=d86f58412df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d86f58412df, replyNumber=0, likeNumber=68, createdTime=2015-11-09, rootId=0, userName=bioon3, userId=322359, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d86f58412df, moduleTitle=NEJM：丙肝药索非布韦对心脏有潜在的毒副作用？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d86f58412df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040116, encodeId=f955204011686, content=<a href='/topic/show?id=ecf72093855' target=_blank style='color:#2F92EE;'>#丙肝药#</a>, objectTitle=吉列德无奈降价回击：CVS**供应吉列德丙肝药物, objectType=article, longId=45242, objectId=742d4524286, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=742d4524286, replyNumber=0, likeNumber=42, createdTime=2015-06-07, rootId=0, userName=bioon3, userId=322359, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=742d4524286, moduleTitle=吉列德无奈降价回击：CVS**供应吉列德丙肝药物, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=742d4524286)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040113, encodeId=77462040113bb, content=<a href='/topic/show?id=ecf72093855' target=_blank style='color:#2F92EE;'>#丙肝药#</a>, objectTitle=吉利德丙肝药物Harvoni获欧盟上市许可, objectType=article, longId=43045, objectId=f673430454f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f673430454f, replyNumber=0, likeNumber=73, createdTime=2015-09-30, rootId=0, userName=bioon3, userId=322359, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f673430454f, moduleTitle=吉利德丙肝药物Harvoni获欧盟上市许可, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f673430454f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040112, encodeId=8f18204011289, content=<a href='/topic/show?id=ecf72093855' target=_blank style='color:#2F92EE;'>#丙肝药#</a>, objectTitle=Achillion丙肝药物ACH-3102二期临床数据良好有望挑战Sovaldi, objectType=article, longId=39211, objectId=2b2b39211da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b2b39211da, replyNumber=0, likeNumber=59, createdTime=2015-01-24, rootId=0, userName=bioon3, userId=322359, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b2b39211da, moduleTitle=Achillion丙肝药物ACH-3102二期临床数据良好有望挑战Sovaldi, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2b2b39211da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040115, encodeId=8617204011581, content=<a href='/topic/show?id=ecf72093855' target=_blank style='color:#2F92EE;'>#丙肝药#</a>, objectTitle=祸不单行，艾伯维、Achillion相继争夺吉利德丙肝药市场, objectType=article, longId=44783, objectId=969944e8346, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=969944e8346, replyNumber=0, likeNumber=0, createdTime=2015-11-08, rootId=0, userName=bioon3, userId=322359, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=969944e8346, moduleTitle=祸不单行，艾伯维、Achillion相继争夺吉利德丙肝药市场, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=969944e8346)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040108, encodeId=29f120401086e, content=<a href='/topic/show?id=ecf72093855' target=_blank style='color:#2F92EE;'>#丙肝药#</a>, objectTitle=吉利德开发新一代丙肝药物, objectType=article, longId=32379, objectId=e82b323e9e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e82b323e9e3, replyNumber=0, likeNumber=66, createdTime=2014-11-03, rootId=0, userName=bioon3, userId=322359, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e82b323e9e3, moduleTitle=吉利德开发新一代丙肝药物, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e82b323e9e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040114, encodeId=d4fe2040114f0, content=<a href='/topic/show?id=ecf72093855' target=_blank style='color:#2F92EE;'>#丙肝药#</a>, objectTitle=功亏一篑！FDA推迟施贵宝丙肝药物daclatasvir上市, objectType=article, longId=43283, objectId=fa2543283fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa2543283fc, replyNumber=0, likeNumber=62, createdTime=2015-08-11, rootId=0, userName=bioon3, userId=322359, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa2543283fc, moduleTitle=功亏一篑！FDA推迟施贵宝丙肝药物daclatasvir上市, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=fa2543283fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040111, encodeId=679f2040111e2, content=<a href='/topic/show?id=ecf72093855' target=_blank style='color:#2F92EE;'>#丙肝药#</a>, objectTitle=美国人民愤怒了——吉利德天价丙肝药Sovaldi印度售价仅1%, objectType=article, longId=38939, objectId=5fa5389396e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5fa5389396e, replyNumber=0, likeNumber=60, createdTime=2015-04-30, rootId=0, userName=bioon3, userId=322359, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5fa5389396e, moduleTitle=美国人民愤怒了——吉利德天价丙肝药Sovaldi印度售价仅1%, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5fa5389396e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040107, encodeId=2e15204010e45, content=<a href='/topic/show?id=ecf72093855' target=_blank style='color:#2F92EE;'>#丙肝药#</a>, objectTitle=EMA授予勃林格丙肝药物faldaprevir加速评估, objectType=article, longId=27222, objectId=c0e12e22280, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0e12e22280, replyNumber=0, likeNumber=55, createdTime=2014-01-03, rootId=0, userName=bioon3, userId=322359, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0e12e22280, moduleTitle=EMA授予勃林格丙肝药物faldaprevir加速评估, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c0e12e22280)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040110, encodeId=14e220401108d, content=<a href='/topic/show?id=ecf72093855' target=_blank style='color:#2F92EE;'>#丙肝药#</a>, objectTitle=EASL 2014：丙肝药物试验大放光彩（SAPPHIRE试验）, objectType=article, longId=33206, objectId=e37f3320613, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e37f3320613, replyNumber=0, likeNumber=56, createdTime=2014-05-10, rootId=0, userName=bioon3, userId=322359, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e37f3320613, moduleTitle=EASL 2014：丙肝药物试验大放光彩（SAPPHIRE试验）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e37f3320613)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040109, encodeId=1b3b2040109e0, content=<a href='/topic/show?id=ecf72093855' target=_blank style='color:#2F92EE;'>#丙肝药#</a>, objectTitle=美国药厂丙肝药上千美元一片引立法者质疑, objectType=article, longId=32385, objectId=e02832385f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e02832385f2, replyNumber=0, likeNumber=60, createdTime=2014-04-27, rootId=0, userName=bioon3, userId=322359, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e02832385f2, moduleTitle=美国药厂丙肝药上千美元一片引立法者质疑, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e02832385f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

丙肝药

2020-05-29

bioon3 (审核中...)

前往app查看评论内容

#丙肝药#

吉利德的丙肝药物Epclusa在儿童感染患者中应答率超过90%，喜获FDA批准

2020-12-27

bioon3 (审核中...)

前往app查看评论内容

#丙肝药#

吉利德全新慢性丙肝药物“吉三代”沃士韦在中国上市，10万以内搞定丙肝

2020-12-18

bioon3 (审核中...)

前往app查看评论内容

#丙肝药#

美国FDA首次批准儿童全基因型抗丙肝药物：艾伯维的Mayyret

2019-06-06

bioon3 (审核中...)

前往app查看评论内容

#丙肝药#

警惕这种仿制丙肝药，会害了成千上万的患者！

2018-04-29

bioon3 (审核中...)

前往app查看评论内容

#丙肝药#

【盘点】近期关于丙肝药-索非布韦的研究进展一览

2018-03-08

bioon3 (审核中...)

前往app查看评论内容

#丙肝药#

EMA支持批准两种丙肝药物Epclusa和Zepatier

2016-11-08

bioon3 (审核中...)

前往app查看评论内容

#丙肝药#

默沙东战胜吉利德，赢取首轮丙肝药专利权大战

2016-07-01

bioon3 (审核中...)

前往app查看评论内容

#丙肝药#

沙东战胜吉利德，赢取首轮丙肝药专利权大战

2016-05-12

bioon3 (审核中...)

前往app查看评论内容

#丙肝药#

NEJM：丙肝药物Sofosbuvir和Velpatasvir联用大获成功，肝硬化依然有效（ASTRAL系列研究）

2016-04-14

bioon3 (审核中...)

前往app查看评论内容

#丙肝药#

NEJM：丙肝药索非布韦对心脏有潜在的毒副作用？

2015-11-09

bioon3 (审核中...)

前往app查看评论内容

#丙肝药#

吉列德无奈降价回击：CVS**供应吉列德丙肝药物

2015-06-07

bioon3 (审核中...)

前往app查看评论内容

#丙肝药#

吉利德丙肝药物Harvoni获欧盟上市许可

2015-09-30

bioon3 (审核中...)

前往app查看评论内容

#丙肝药#

Achillion丙肝药物ACH-3102二期临床数据良好有望挑战Sovaldi

2015-01-24

bioon3 (审核中...)

前往app查看评论内容

#丙肝药#

祸不单行，艾伯维、Achillion相继争夺吉利德丙肝药市场

2015-11-08

bioon3 (审核中...)

前往app查看评论内容

#丙肝药#

吉利德开发新一代丙肝药物

2014-11-03

bioon3 (审核中...)

前往app查看评论内容

#丙肝药#

功亏一篑！FDA推迟施贵宝丙肝药物daclatasvir上市

2015-08-11

bioon3 (审核中...)

前往app查看评论内容

#丙肝药#

美国人民愤怒了——吉利德天价丙肝药Sovaldi印度售价仅1%

2015-04-30

bioon3 (审核中...)

前往app查看评论内容

#丙肝药#

EMA授予勃林格丙肝药物faldaprevir加速评估

2014-01-03

bioon3 (审核中...)

前往app查看评论内容

#丙肝药#

EASL 2014：丙肝药物试验大放光彩（SAPPHIRE试验）

2014-05-10

bioon3 (审核中...)

前往app查看评论内容

#丙肝药#

美国药厂丙肝药上千美元一片引立法者质疑

2014-04-27

科室
- - 订阅+
  - 更多科室
工具
服务